• Home
  • PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer.

PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer.

Author List
Hope TA, Calais J
Publication
Lancet (London, England)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/175823629
Publication Year
2021
PubMed ID
33581799
Publication Title
Hope TA, Calais J. PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer. Lancet. 2021 02 27; 397(10276):768-769.